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Background: Obesity is an increasing public health
problem affecting young people. Behavioural treatment is
the mainstay of weight control programs for obese teens.
Traditional behavioural-based programs are usually done
face-to-face by health professionals and include strategies
to increase physical activity and modify dietary habits.
However, seeing medical professionals for individual
consultation to discuss weight management on a regular
basis can be expensive and time-consuming. In addition,
many Hong Kong adolescents rely heavily on the internet
to acquire updated knowledge and cell phone texting for
communication.
Research purpose: We undertook a pilot study
investigated the feasibility of using both an adapted internet-
based curriculum with cell phone reminders and a simplified
lifestyle modification programme (sLMP), consisting of
four nutritional counselling sessions, as adjuncts to usual
care for obese adolescents and their parents. Here we report
on the feasibility of using cell phone reminders for weight
management.
Methods: Forty-eight obese Chinese teens aged 12 to
18 years were randomised into three groups (control group,
internet intervention (IT) group, sLMP group). The study
was conducted over 24 weeks. IT group subjects were asked
to view a 12-week internet-based curriculum weekly and
to set specific goals related to (a) diet and (b) physical
activity at baseline and then every month. A weekly semi-
personalised SMS (incorporating subjects' diet and exercise
goals) was sent to participants and they were asked to reply
with an emotion icon to represent whether they had
achieved their targets during the week. Participants were
also asked in these SMSs about factors which were
incentives or barriers to meeting dietary and exercise goals.
Results: The most preferred dietary and physical activity
goals were eating at least two servings of fruit (62.5%) and
increasing frequency of exercise by doing 30 minutes of
moderate to vigorous activity three to five times per week
(75%), respectively. A total of 400 messages were sent to
the 16 subjects. Fifteen subjects opted to receive the
message by Whatsapp and one preferred email. The research
assistant spent an average of 2 hours per week to send out
the personalised cell phone reminders to the 16 participants.
Participants' response rate to meeting dietary and exercise
goals were 78.3% and 77.5%, respectively. However,
response rate for stating personal incentives and barriers
were 51.4% and 47%, respectively. All subjects and nearly
93.8% of parents found the weekly SMS and setting dietary
and exercise goals useful or very useful in terms of
managing their child's obesity.
Conclusions: The findings suggest that the use of cell
phone reminders is feasible and well accepted by
participants. Given that mobile phones are a common device
among adolescents, setting specific goals related to dietary
and physical activity along with personalised cell phone
reminders may be an innovative adjunct to usual care of
obesity. Further study is required to determine whether this
intervention is a cost-effective approach to changing weight
and promoting a healthy lifestyle in obese youth.
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While there are various factors influencing clients'
decisions about genetic testing; testing for the sake of others
is not uncommon. This paper focuses on decisions about
testing (DOT) when a genetic mutation is identified in a
Sudden Arrhythmia Death Syndromes (SADS) patient and
it is unclear whether the mutation is the cause of the disease.
Family members are then asked to consider genetic testing
to ascertain the client’s genetic status and future risk. The
paper examines, at the interactional level, how genetic
counselors, clients and family members negotiate decision-
making involving others.
The data consists of 23 video-recorded consultations
obtained from a Hong Kong hospital. Episodes of decision-
making about testing are identified and extracted from the
transcribed data. By using theme-oriented discourse
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analysis, the analysis focuses on the discourse strategies
that participants employ to foreground the possible benefits
when other family members undergo the genetic test.
Preliminary findings show a disjuncture of perspectives
between genetic counselors and family members in terms
of the benefits of testing. While genetic counselors see
testing as a means of confirming the diagnosis and
managing risk, family members voice concerns about the
usefulness of the test for a client's treatment. To mitigate
these different perspectives on DOT, participants use a
range of discourse strategies,  such as contrast,
foregrounding, self-and-other construction as a way of
emphasizing future scenarios. This study, in sum,
elucidates how other-oriented decisions are made in the
clinical setting.
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Background: Ganoderma Lucidum (G.lucidum or
Lingzhi, ) is a form of fungus that has been used as
medication for a long time. G.lucidum has been advocated
to enhance health and longevity. It has been applied to a
wide spectrum of diseases including hypertension and
cancer. One of the major bioactive components in
G.lucidum is β-glucan. β-glucans are glucose polymers
joined together by β-1-3 / 1-6 glycosidic linkages. Human
does not have the enzymes to digest the β-1-3 / 1-6
glycosidic bonds and therefore the glucose polymers form
3-dimensional helical structures after ingestion and activate
immune cells via dectin-1 receptor. However, most of the
fungi also have β-glucans in their cell wall and therefore
β-glucans found in the blood can be used a marker for the
diagnosis of fungal infection. Chromogenic Limulus
Ameobyocyte Lysate (LAL) assay (Fungitell, Pyrochrome,
Associates of Cape Cod, Inc, East Falmouth, USA) is the
commercial product designed for the detection and
quantitation of β-glucans, especially the β-(1, 3)-glucans.
Fungitell is now approved by FDA for clinical diagnosis of
fungal infection. However, whether the intake of the β-
glucans containing products such as Lingzhi may affect
the serum β-glucans level remains unknown.
Methods: The commercially available G.lucidum
products are provided by YorkBest International, Hong
Kong. The β-glucans level has been confirmed previously
by our group. Oral dosage in this study followed the
manufacturing instructions (2 to 4 capsules). The serum
samples from patients with confirmed fungal infection were
retrieved from the department of Microbiology in order to
assess the specificity and sensitivity of the Fungitell kit.
Pre/Pro blood samples were collected from the volunteers
before and 1hr after the intake of G.lucidum. The serum
β-glucans level was then measured by Fungitell kit
according to the manufacturer's instruction. The β-glucans
level <60pg/mL is considered as negative, whereas, the
values >80pg/mL is considered as positive. The values
between 60 to 79pg/mL are considered as indeterminate.
The data was analysed by GraphPad Prism version 5.0
software (GraphPad Software Inc, CA, USA). Comparisons
between means were based on paired student's t test.
Results: Fungitell test results of patients with confirmed
fungal infection shown that 5 out of 11 were detected as
positive whereas another 5 were detected as negative. One
out of 11 was detected as equivocal. The data showed no
correlation between the fungal agents and the serum β-
glucans level. The 11 confirmed fungal infection patient
samples were considered as positive population while the
11 healthy donors were considered as negative population.
True positive was 5 but the false negative was also 5. Since
all the healthy donors were negative, the true negative cases
were considered as 11 and false positive was considered as
0. In this study, all the samples from pre/pro blood collection
after the intake of the β-glucans containing products fell
into negative range. No significant statistical difference was
observed when comparing the results from pre/pro blood
samples.
Conclusion: Fungitell test has a sensitivity of 50% and
specificity of 100% in detecting various fungal infections.
The positive predictive value is 100% while the negative
predictive value is 68.75%. The accuracy is 72.72%. It is
non-specific for various fungi. The oral intake of β-glucans
containing products did not affect the serum β-glucans level
by using Fungitell assay.
